IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen ...

Meanwhile, Amgen’s offer price is at an approximately 20% premium to Horizon’s closing price of €92.48 ($97.29) on Friday 9 th December. Californian biotech Amgen’s own market value is ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN – Research Report) and Align Tech (ALGN – ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...

Shares of Amgen Inc. AMGN rose 1.62% to $285.98 Friday, on what proved to be an all-around great trading session for the ...

Amgen has gotten caught up in the broader market decline, but its business is unscathed. Its obesity drug sales are about to boom, making the stock look like a buy.

Shares in Horizon Therapeutics have been in sharp decline after reports emerged that the US financial regulator is preparing a challenge to its $28 billion takeover by Amgen. The stock fell 18% in ...

Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA as the first and only treatment for adults living with Immunoglobulin G4-related disease (IgG4 ...

The Legend of Heroes: Trails Beyond the Horizon will be available on Nintendo Switch, PS4 (PlayStation 4), PS5 (PlayStation 5), and PC in Fall 2025.The prophesied end of the Zemurian continent ...